Administration of kefir-fermented milk protects mice against Giardia intestinalis infection
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Giardiasis, caused by the protozoan Giardia intestinalis, is one of the most common intestinal diseases worldwide and constitutes an important problem for the public health systems of various countries. Kefir is a probiotic drink obtained by fermenting milk with ‘kefir grains’, which consist mainly of bacteria and yeasts that coexist in a complex symbiotic association. In this work, we studied the ability of kefir to protect mice from G. intestinalis infection, and characterized the host immune response to this probiotic in the context of the intestinal infection. Six- to 8-week-old C75BL/6 mice were separated into four groups: controls, kefir mice (receiving 1 : 100 dilution of kefir in drinking water for 14 days), Giardia mice (infected orally with 4×10 7 trophozoites of G. intestinalis at day 7) and Giardia–kefir mice (kefir-treated G. intestinalis-infected mice), and killed at 2 or 7 days post-infection. Kefir administration was able to significantly reduce the intensity of Giardia infection at 7 days post-infection. An increase in the percentage of CD4+ T cells at 2 days post-infection was observed in the Peyer’s patches (PP) of mice belonging to the Giardia group compared with the control and kefir groups, while the percentage of CD4+ T cells in PP in the Giardia–kefir group was similar to that of controls. At 2 days post-infection, a reduction in the percentage of B220-positive major histocompatibility complex class II medium cells in PP was observed in infected mice compared with the other groups. At 7 days post-infection, Giardia-infected mice showed a reduction in RcFcϵ-positive cells compared with the control group, suggesting a downregulation of the inflammatory response. However, the percentages of RcFcϵ-positive cells did not differ from controls in the kefir and Giardia–kefir groups. An increase in IgA-positive cells was observed in the lamina propria of the kefir group compared with controls at 2 days post-infection. Interestingly, the diminished number of IgA-positive cells registered in the Giardia group at 7 days post-infection was restored by kefir feeding, although the increase in IgA-positive cells was no longer observed in the kefir group at that time. No significant differences in CXCL10 expression were registered between groups, in concordance with the absence of inflammation in small-intestinal tissue. Interestingly, a slight reduction in CCL20 expression was observed in the Giardia group, suggesting that G. intestinalis might downregulate its expression as a way of evading the inflammatory immune response. On the other hand, a trend towards an increase in TNF-α expression was observed in the kefir group, while the Giardia–kefir group showed a significant increase in TNF-α expression. Moreover, kefir-receiving mice (kefir and Giardia–kefir groups) showed an increase in the expression of IFN-γ, the most relevant Th1 cytokine, at 2 days post-infection. Our results demonstrate that feeding mice with kefir reduces G. intestinalis infection and promotes the activation of different mechanisms of humoral and cellular immunity that are downregulated by parasitic infection, thus contributing to protection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Guidelines for the evaluation of probiotics in food
Who, F. (2002) · Medical Entomology and Zoology · Cited by 1,843
Functional cultures and health benefits
Shah, N. P. (2007) · International Dairy Journal · doi:10.1016/j.idairyj.2007.01.014 · Cited by 787 · cited 1×
“Probiotic micro-organisms can exert their beneficial actions through various different mechanisms, including competitive exclusion or inhibition of pathogens, modulation of the immune response, modification of intestinal microbiota and regulation of metabolic functions (Shah, 2007).”
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
Liu, M., Guo, S., Hibbert, J. M., Jain, V., Singh, N., Wilson, N. O., & Stiles, J. K. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.06.001 · Cited by 751 · cited 1×
“On the other hand, CXCL10 (also known as IP-10) is a pro-inflammatory mediator that mediates the attraction of different immune cell populations to inflamed or infected areas (Liu et al., 2011).”
Gardner, T. B., & Hill, D. R. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.114-128.2001 · Cited by 565
Galdeano, C. M., & Perdigón, G. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.2.219-226.2006 · Cited by 535 · cited 1×
“…several authors have reported that the administration of probiotic bacteria can induce an increase in CD4 + T cells (Benyacoub et al ., 2005; Vinderola et al ., 2007; Goyal & Shukla, 2013), no changes were registered in other cases (Vitin˜i et al ., 2000; Galdeano & Perdigo´n, 2006; Humen, 2009).”
Farnworth, E. R. (2005) · Food Science <html_ent glyph="@amp;" ascii="&"/> Technology Bulletin: Functional Foods · doi:10.1616/1476-2137.13938 · Cited by 422 · cited 2×
“Because several health-promoting properties, such as antimicrobial, antitumoral, hypocholesterolaemic and immunomodulating effects, have been associated with the consumption of kefir, this milk might be considered a probiotic product (Farnworth, 2005; Lopitz-Otsoa et al., 2006).”
Chemical and microbiological characterisation of kefir grains
GARROTE, G. L., ABRAHAM, A. G., & DE ANTONI, G. L. (2001) · Journal of Dairy Research · doi:10.1017/s0022029901005210 · Cited by 332 · cited 4×
“Commercial UHT milk and kefir grains AGK1 from the CIDCA (Centro de Investigación y Desarrollo en Criotecnologı́a de Alimentos) collection were used to obtain the fermented milk (Garrote et al., 2001).”
InfluentialImmune Response to Giardia duodenalis
Faubert, G. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.35-54.2000 · Cited by 279 · cited 5×
“…cells, and taking into account that other authors have associated low levels of this cytokine with an increased susceptibility to Giardia infection (Faubert, 2000), we hypothesize that the increase in the expression of IFN-c induced by kefir feeding could contribute to the protective effect of…”
InfluentialCCR6 as a mediator of immunity in the lung and gut
Ito, T., Carson, W. F., Cavassani, K. A., Connett, J. M., & Kunkel, S. L. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.018 · Cited by 248 · cited 1×
“CCL20 is secreted by enterocytes in response to different inflammatory stimuli and can induce the migration of immature dendritic cells and lymphocytes (Ito et al., 2011).”
Host parasite interactions and pathophysiology in Giardia infections
Cotton, J. A., Beatty, J. K., & Buret, A. G. (2011) · International Journal for Parasitology · doi:10.1016/j.ijpara.2011.05.002 · Cited by 241 · cited 2×
“This parasite can infect children, adults and immunocompromised individuals, leading to acute or chronic diarrhoea, malabsorption, weight loss and growth delay in young children (Faubert, 2000; Cotton et al ., 2011).”
Research works printed but not linked: 1
- Humen, 2009, Interacción de Giardia intestinalis con el hospedador efecto antagónico de probióticos intestinales
Cited by
The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir
Bourrie, B. C. T., Willing, B. P., & Cotter, P. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00647 · Cited by 438
“This impact was mediated through increases in the levels of TNF-α and IFN-γ expression and through higher levels of IgA positive and RcFcε positive cells (Correa Franco et al., 2013).”
BackgroundResultInfluentialMilk kefir : nutritional, microbiological and health benefits
Rosa, D. D., Dias, M. M. S., Grześkowiak, Ł. M., Reis, S. A., Conceição, L. L., & Peluzio, M. D. C. G. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000275 · Cited by 463
Kefir and Its Biological Activities
Azizi, N. F., Kumar, M. R., Yeap, S. K., Abdullah, J. O., Khalid, M., Omar, A. R., Osman, M. A., Mortadza, S. A. S., & Alitheen, N. B. (2021) · Foods · doi:10.3390/foods10061210 · Cited by 256
Farag, M. A., Jomaa, S. A., Abd El-Wahed, A., & R. El-Seedi, H. (2020) · Nutrients · doi:10.3390/nu12020346 · Cited by 251
“Feeding mice with kefir reduces protozoan Giardia intestinalis infection and promotes the activation of different mechanisms of humoral and cellular immunity that are down-regulated by this parasitic infection [122].”
BackgroundA review: chemical, microbiological and nutritional characteristics of kefir
Arslan, S. (2015) · CyTA - Journal of Food · doi:10.1080/19476337.2014.981588 · Cited by 160
“In another study, the addition of kefir caused a reduction in the level of Giardia intestinalis infection 7 days post-infection (Franco et al., 2013).”
BackgroundAdvances in understanding Giardia: Determinants and mechanisms of chronic sequelae
Bartelt, L. A., & Sartor, R. B. (2015) · F1000Prime Reports · doi:10.12703/p7-62 · Cited by 154
Impact of Kefir Derived Lactobacillus kefiri on the Mucosal Immune Response and Gut Microbiota
Carasi, P., Racedo, S. M., Jacquot, C., Romanin, D. E., Serradell, M. A., & Urdaci, M. C. (2015) · Journal of Immunology Research · doi:10.1155/2015/361604 · Cited by 145
“These findings are in agreement with results reported for some lactobacillibased probiotics [50, 51] or even for the administration of kefir-fermented milk [16, 52].”
ResultSelf-citationBalasubramanian, R., Schneider, E., Gunnigle, E., Cotter, P. D., & Cryan, J. F. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105562 · Cited by 153
“Similar reductions in the levels of inflammatory cytokines, especially IFN-γ and TNF-α , were observed in the colon of mice receiving milk kefir post-infection with Giardia intestinalis (Franco et al., 2013).”
Brazilian Kefir-Fermented Sheep’s Milk, a Source of Antimicrobial and Antioxidant Peptides
de Lima, M. D. S. F., da Silva, R. A., da Silva, M. F., da Silva, P. A. B., Costa, R. M. P. B., Teixeira, J. A., Porto, A. L. F., & Cavalcanti, M. T. H. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9365-8 · Cited by 117
“zyme activity and the absorption of nutrients [11], and protects against Giardia intestinalis infection [12].”
BackgroundInteractions of Giardia sp.with the intestinal barrier: Epithelium, mucus, and microbiota
Allain, T., Amat, C. B., Motta, J.-P., Manko, A., & Buret, A. G. (2017) · Tissue Barriers · doi:10.1080/21688370.2016.1274354 · Cited by 101
“) and yeast (Sacharomyces cerevisae, Candida spp).(111,112)”
Kim, D.-H., Jeong, D., Kim, H., & Seo, K.-H. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1428168 · Cited by 100
Pathogenesis and post-infectious complications in giardiasis
Allain, T., & Buret, A. G. (2019) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2019.12.001 · Cited by 111
Giardia spp. and the Gut Microbiota: Dangerous Liaisons
Fekete, E., Allain, T., Siddiq, A., Sosnowski, O., & Buret, A. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.618106 · Cited by 86
Safety Characterization and Antimicrobial Properties of Kefir-Isolated Lactobacillus kefiri
Carasi, P., Díaz, M., Racedo, S. M., De Antoni, G., Urdaci, M. C., & Serradell, M. D. L. A. (2014) · BioMed Research International · doi:10.1155/2014/208974 · Cited by 67
“Research Article”
Self-citationProbiotics in valorization of innate immunity across various animal models
Patel, S., Shukla, R., & Goyal, A. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.02.022 · Cited by 70
Host defences against Giardia lamblia
Lopez‐Romero, G., Quintero, J., Astiazarán‐García, H., & Velazquez, C. (2015) · Parasite Immunology · doi:10.1111/pim.12210 · Cited by 61
de Carvalho, A. P. A., & Conte‐Júnior, C. A. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.07.038 · Cited by 65
Novel Functional Whey-Based Drinks with Great Potential in the Dairy Industry
Pereira, C., Henriques, M., Gomes, D., Gómez‐Zavaglia, A., & Antoni, G. D. (2015) · Food Technology and Biotechnology · doi:10.17113/ftb.53.03.15.4043 · Cited by 57
Cross-kingdom inhibition of bacterial virulence and communication by probiotic yeast metabolites
Malka, O., Kalson, D., Yaniv, K., Shafir, R., Manikandan, R., Ben‐David, O., Kushmaro, A., Meijler, M. M., & Jelinek, R. (2021) · Microbiome · doi:10.1186/s40168-021-01027-8 · Cited by 40
Effect of probiotics on giardiasis. Where are we?
Ventura, L. L. A., de Oliveira, D. R., Gomes, M. A., & Torres, M. R. F. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000217360 · Cited by 40
Potential beneficial effects of kefir and its postbiotic, kefiran, on child food allergy
Barros, S. É. D. L., Rocha, C. D. S., de Moura, M. S. B., Barcelos, M. P., da Silva, C. H. T. D. P., & Hage-Melim, L. I. D. S. (2021) · Food & Function · doi:10.1039/d0fo03182h · Cited by 35
Host-Directed Therapies for Parasitic Diseases
Singh, B., Varikuti, S., Halsey, G., Volpedo, G., Hamza, O., & Satoskar, A. R. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0439 · Cited by 33
Gamba, R. R., Colo, C. N., Corrêa, M. F. D., Astoreca, A., Alconada, T. M., Antoni, G. D., & Peláez, Á. M. L. (2015) · Advances in Microbiology · doi:10.4236/aim.2015.56049 · Cited by 27
“subtilis, Staphyulococcus aures and Giardia intestinalis [20]-[23].”
Anti-inflammatory pathways of kefir in murine model: a systematic review
Pereira, M. D. F. A., Albuini, F. M., & Pelúzio, M. D. C. G. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad052 · Cited by 27
Culpepper, T. (2022) · Cureus · doi:10.7759/cureus.27768 · Cited by 28
“In another study using mice infected with Giardia intestinalis, kefir decreased the amount of viable luminal trophozoites and increased the number of IgA-positive lamina propria cells in the small intestines [47].”
BackgroundPerformance of Holstein calves fed whole milk with or without kefir
Fouladgar, S., Shahraki, A. D. F., Ghalamkari, G., Khani, M., Ahmadi, F., & Erickson, P. S. (2016) · Journal of Dairy Science · doi:10.3168/jds.2016-10921 · Cited by 27
“Past studies indicated that feeding mice with kefir is associated with health benefits (Vinderola et al., 2005; Vinderola et al., 2006; Franco et al., 2013), possibly due to antimicrobial and antagonistic activities against pathogens, which is mainly attributed to the presence of hydrogen peroxide,…”
BackgroundWang, X., Tian, J., Zhang, X., Tang, N., Rui, X., Zhang, Q., Dong, M., & Li, W. (2022) · Foods · doi:10.3390/foods11213330 · Cited by 22
“Basic research and clinical treatment have shown the great health benefits of kefir including antitumor [4], immunomodulatory [5], wound healing [6], and anti-allergenic effects [7].”
BackgroundAdministration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease
Spinler, J. K., Brown, A., Ross, C. L., Boonma, P., Conner, M. E., & Savidge, T. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.008 · Cited by 24
“A mouse model of giardiasis showed that oral administration of kefir reduced infection with Giradia intestinalis by activating a variety of humoral and cellular immune responses typically downregulated during parasitic infection [31].”
BackgroundProbiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes
Dashti, N., & Zarebavani, M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02124-z · Cited by 21
Evaluation of the subchronic toxicity of kefir by oral administration in Wistar rats.
Rosa, D. D., Pelúzio, M. D. C. G., Bueno, T. P., Cañizares, E. V., Miranda, L. S., Dorbignyi, B. M., Chong, D., Castaño, I. E., Kowiak, L. M. G., & Ferreira, C. L. D. L. F. (2014) · PubMed · doi:10.3305/nh.2014.29.6.7390 · Cited by 19
Kefir Beverage and Its Effects on Health
Noğay, N. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815504-2.00008-6 · Cited by 40
Malka, O., Malishev, R., Bersudsky, M., Manikandan, R., Krishnamohan, M., Shaik, J., Chamovitz, D., Tikhonov, E., Sultan, E., Koren, O., et al. (2023) · Journal of Innate Immunity · doi:10.1159/000529782 · Cited by 14
“been known to bolster the innate immune system and host-defense mechanisms against pathogens [17,18].”
BackgroundRolny, I. S., Tiscornia, I. S., Racedo, S., Pérez, P. F., & Bollati‐Fogolín, M. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0191 · Cited by 17
Self-citationKaraffová, V., Mudroňová, D., Maďar, M., Hrčková, G., Faixová, D., Gancarčíková, S., Ševčíková, Z., & Nemcová, R. (2021) · Microorganisms · doi:10.3390/microorganisms9040831 · Cited by 15
“These changes were accompanied by significantly higher numbers of IgA-positive cells and higher gene expression for IFN-γ and TNF-α in the small intestine [41].”
BackgroundFermented dairy products based on ovine cheese whey
Pereira, C., Henriques, M., Gomes, D., Gouveia, R. D. S., Gómez‐Zavaglia, A., & Antoni, G. D. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1857-5 · Cited by 13
“…liquid-type fermented products based on: (a) well-characterized kefir grains (Londero et al. 2012) containing microorganisms active against pathogenic bacteria (Golowczyc et al. 2007) or parasites (Franco et al. 2013); (b) a commercial mix of probiotic bacteria; and (c) a mixture of (a) and (b).”
BackgroundMethodEffect of Kefir on Fusobacterium nucleatum Potentially Causing Intestinal Cancer
Güzel‐Seydim, Z. B., Cagdas, M. D. E., & Seydim, A. C. (2016) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v6i7.272 · Cited by 14
Laskowska, E., Jarosz, Ł. S., & Grądzki, Z. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9460-5 · Cited by 13
Small- and Large-Scale Production of Probiotic Foods, Probiotic Potential and Nutritional Benefits
Akhtar, G., Bhat, N. A., Masoodi, F. A., & Gani, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00023-x · Cited by 16
Alimi, D., Rekik, M., & Akkari, H. (2018) · Journal of Helminthology · doi:10.1017/s0022149x18000378 · Cited by 11
Ryan, S. M., & Brayden, D. J. (2026) · Frontiers in Drug Delivery · doi:10.3389/fddev.2026.1692219 · Cited by 14
“Kefir also provided protective effects in Giardia intestinalis infections in C57BL/6 mice, likely through immune modulation (Franco et al., 2013).”
Sodanlo, A., & Azizkhani, M. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10181-4 · Cited by 9
Hajare, S. T. (2021) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2021.1895217 · Cited by 5
“The results are in line with observations recorded by Franco et al., 2013[45,46] and Vinderola et al., 2005 [46] who treated mice with kefir containing yeasts and acetic acid bacteria and found an increase in the percentage of phagocytic cells and an increase in production of TNF-α and IL-6 by…”
ResultEryilmaz, H., İnce, O. K., & İnce, M. (2022) · International Journal of Pure and Applied Sciences · doi:10.29132/ijpas.1134231 · Cited by 3
Immunosuppressive Activity of Goat Kefir in a Rat Model with Bleomycin-induced Pulmonary Fibrosis
Griana, T. P., Raras, T. Y. M., Mintaroem, K., Chozin, I. N., & Wilujeng, C. S. (2020) · Pharmacognosy Journal · doi:10.5530/pj.2020.12.218 · Cited by 3
Regulation effect of Lactobacillus johnsonii on chickens infected with Ascaridia galli
Xu, Z.-H., Mo, K.-Z., Cai, P.-X., Xu, J., & Han, Q. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106399 · Cited by 2
“…infection of various intestinal parasites in mammals by promoting the activity of antioxidant enzymes and macrophages, as well as modulating the expression of inflammatory factors (Cadore et al., 2021; Franco et al., 2013; Goyal et al., 2011; Shukla et al., 2008, 2013; Var-gov ´ a et al., 2020).”
Pereira, M. D. F. A., de Ávila, L. G. M., Cruz, B. C. D. S., Almeida, L. F., Simões, J. M., Silva, B. C., Aguilar, A. P., de Oliveira, L. L., Gonçalves, R. V., Ribon, A. D. O. B., et al. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae249 · Cited by 3
Kefir revisited: Insights from the North Caucasus
Katchieva, P. K., Katchieva, K. K., Kipkeeva, F. I., Kharaeva, Z. F., & Smeianov, V. V. (2025) · World Journal of Experimental Medicine · doi:10.5493/wjem.v15.i4.112191 · Cited by 2
Montalvo-Corral, M., Clark, L. P., Robles, G. L., Duarte, I. R., Cervantes, G. L., & Moya-Camarena, S. Y. (2018) · Nova Scientia · doi:10.21640/ns.v10i21.1578 · Cited by 1
“Franco et al. (2013), observaron en un modelo de giardiasis inducida en hembras C57BL/6, que la suplementación con yogur Kéfir disminuía también la carga parasitaria a niveles un poco más altos a los encontrados en nuestro estudio.”
BackgroundCarasi, P. (2014) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/43573 · Cited by 5
IDENTIFICAÇÃO PRESUNTIVA DE LEVEDURAS DE INTERESSE BIOTECNOLÓGICO EM GRÃOS DE KEFIR
ANTONIASSI, F. M., Martins, B. L., & de Queiroz-Fernandes, G. M. (2017) · Acta Biomédica Brasiliensia · doi:10.18571/acbm.145a · Cited by 2
Franco, M. C. (2018) · doi:10.35537/10915/66124 · Cited by 1
Self-citationProbióticos basados en bifidobacterias: interacción con células fagocíticas y acenocumarol
Assad, S. (2019) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/88296
Productos fermentados deshidratados probióticos para la prevención de giardiasis
Teijeiro, M. (2019) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/88859
Bourrie, B. C. T. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-p44t-f154
A review on impact of carbonated milk beverages on human health
Kumari, S., Sharma, S. P., Verma, M., Raj, D., Solanki, D., Singh, S., & Kasana, A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.6343
“The additional study recommended that from consuming kefir the seriousness of giardia intestinal infection in rats might get alleviated (Franco et al., 2013).”
BackgroundAntifungal Activity of Peptides Derived From Iranian Traditional Kefir
Azizkhani, M., & Sodanlo, A. (2021) · International Journal of Enteric Pathogens · doi:10.34172/ijep.2021.20
Protozoon Kaynaklı Enfeksiyonların Kontrolünde Probiyotikler
Ölmez, N., Aydın, N., & Barış, S. A. R. I. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1525
Veteriner Bilimlerinde Probiyotiklerin Terapötik, Profilaktik ve Fonksiyonel Kullanımı
Karadağoğlu, Ö., Rıaz, R., Çıldır, Ö. Ş., Makav, M., Kaya, K., Küçükoflaz, M., AYDIN, E., Ölmez, M., Şahin, T., Sezer, M., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358
Helmint Kaynaklı Enfeksiyonların Kontrolünde Probiyotikler
Aydın, N., Ölmez, N., & Barış, S. A. R. I. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1524
Köpek ve Kedilerde Yeni Gelişmeler: Probiyotikler
Batı, Y. U., Sezer, M., & Akyüz, E. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1523
Obezitede Probiyotiklerin Glukoz ve Lipid Metabolizması Üzerine Etkisi
Aygörmez, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1526
Genetiği Değiştirilmiş Probiyotikler
Çıldır, Ö. Ş. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1516
Moure, M. C. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/176076 · Cited by 1
Therapeutics Potential of Animal-Based Fermented Foods
Paul, V., Reji, S., & Rajesh, S. (2025) · Springer eBooks · doi:10.1007/978-3-032-00575-5_14
Chiani, F. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1628474
Malka, O., Kalson, D., Yaniv, K., Shafir, R., Rajendran, M., Ben-David, O., Kushmaro, A., Meijler, M. M., & Jelinek, R. (2021) · Figshare · doi:10.6084/m9.figshare.14300305
Impact of spray-dried Lactiplantibacillus plantarum CIDCA 83114 on a murine model of giardiasis
Teijeiro, M., Antoni, G. L. D., Golowczyc, M. A., & Pérez, P. F. (2026) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2026.100721 · Cited by 1
Self-citation
Metadata
- Authors
- Franco, M. C., Golowczyc, M. A., De Antoni, G. L., Pérez, P. F., Humen, M., & Serradell, M. D. L. A.
- Affiliations
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Cátedra de Microbiología, Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, 47 y 115, La Plata, Argentina
- ORCID
- Pérez, Pablo F.
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2013-12-01
- Volume
- 62
- Issue
- 12
- Pages
- 1815-1822
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- OpenAlex
- W2148007167
- Cited by
- 65
- References
- 44
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 8 · 2022: 4 · 2021: 12 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 4
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-sa
- Locations
- Journal of Medical Microbiology (publishedVersion)
- PubMed (publishedVersion)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Funders
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Universidad Nacional de La Plata
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- kefir, Giardia lamblia, giardiasis, probiotics, intestinal infection, host immune response, Peyer's patches, CD4+ T cells, IgA, lamina propria, CXCL10, CXCL17, CXCL16, CXCL18
- MeSH terms
- Animals, B-Lymphocytes, Female, Fermentation, Genes, MHC Class II, Giardiasis, Immunoglobulin A, Inflammation, Interferon-gamma, Intestine, Small, Mast Cells, Mice, Inbred C57BL, Milk, Mucous Membrane, Peyer's Patches, Tumor Necrosis Factor-alpha, CD4-Positive T-Lymphocytes, Down-Regulation, Giardia lamblia, Chemokines, Cultured Milk Products, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.